| BSX RSI Data | ||||||||||
Also see: |
BSX RSI: Boston Scientific Relative Strength Index
BSX RSI is 34.71 as of 7/14/2026, with Boston Scientific trading at 42.63. The Relative Strength Index compares recent gains and losses to help identify overbought or oversold momentum. Traditional RSI thresholds often view readings below 30 as oversold and readings above 70 as overbought.
34.71| BSX RSI Chart |
  |
| About Boston Scientific Corp. |
| Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. When researching a stock like Boston Scientific, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BSX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BSX stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of these ways is called the Relative Strength Index, or RSI. This popular indicator, originally developed in the 1970's by J. Welles Wilder, looks at a 14-day moving average of a stock's gains on its up days, versus its losses on its down days. The resulting BSX RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. A reading below 30 is viewed to be oversold, which a bullish investor could look to as a sign that the selling is in the process of exhausting itself, and look for entry point opportunities. A reading above 70 is viewed to be overbought, which could indicate that a rally in progress is starting to get crowded with buyers. If the rally has been a long one, that could be a sign that a pullback is overdue. |
| BSX Current Stock Quote |
Quotes delayed 20 minutes  Free BSX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| BSX Stock Price Chart |
| Video: RSI Indicator | |
|
Video: RSI Indicator
| BSX RSI Peers |
| Boston Scientific (BSX) is categorized under the Healthcare sector; to help you further research RSI, below are some other companies in the same sector:
CAH RSI CI RSI CNC RSI COO RSI COR RSI CRH RSI CRL RSI CVS RSI DGX RSI DHR RSI More Healthcare companies » |
BSX RSI: Boston Scientific Relative Strength Index Chart | www.StockRSI.com | Copyright © 2019 - 2026, All Rights Reserved
Nothing in StockRSI.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.